(Q39485959)

12 September 2017

Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma (English)

1 reference

12 September 2017

1 reference

1 reference

Xianzheng Li

1

1 reference

12 September 2017

Jianmei Wang

2

1 reference

12 September 2017

Xiaojing Zhang

3

1 reference

12 September 2017

Yuanfeng Zeng

4

1 reference

12 September 2017

Li Liang

5

1 reference

12 September 2017

Yanqing Ding

6

1 reference

12 September 2017

23 August 2011

1 reference

Annals of Surgical Oncology

12 September 2017

1 reference

12 September 2017

19

1 reference

12 September 2017

145-153

1 reference

12 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-011-1944-4

12 September 2017

0 references

cites work

Metastasis suppressors alter the signal transduction of cancer cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

21 January 2018

RHO-GTPases and cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Tumor progression: Small GTPases and loss of cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Rho GTPases and signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

RhoGDI: multiple functions in the regulation of Rho family GTPase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

GDIs: central regulatory molecules in Rho GTPase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

RhoGDI2 as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Changes in gene expression during progression of ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Validation of a model of colon cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Up-regulation of RhoGDI2 in human breast cancer and its prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Pathological roles of MAPK signaling pathways in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

A minireview: the role of MAPK/ERK and PI3K/Akt pathways in thyroid follicular cell-derived neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Epithelial-mesenchymal transition and tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1944-4

10.1245/S10434-011-1944-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1035998027

0 references

Fatcat ID

release_ac6jsl7tlff6vpsv35jjsr4pxq

0 references

1 reference